Crit Care Nurse 2002 Aug; 22(4): 41-46
Clinical Article
Using a Reservoir Nasal Cannula in Acute Care
Cheryl Plate Dumont, RN, MSN, CCRN
Brian L. Tiep, MD
Cheryl Plate Dumont was a clinical educator at Winchester Medical Center when the article was written. She is now a per diem intensive care unit nurse at Winchester Medical Center, a member of the adjunct faculty, Division of Nursing, Shenandoah University, in Winchester, Va, and beginning doctoral studies in nursing at the University of Virginia.
Brian L. Tiep is affiliated with Pulmonary Care Continuum and Western University of Health Sciences, Pomona, Calif.
To purchase reprints, contact The InnoVision Group, 101 Columbia, Aliso Viejo, CA 92656. Phone, (800) 809-2273 or (949) 362-2050 (ext 532); fax, (949) 362-2049; e-mail, reprints{at}aacn.org.
Oxymizer and Oxymizer Pendant (CHAD Therapeutics Inc, Chatsworth, Calif) brand reservoir cannulas store oxygen in a reservoir during exhalation and deliver a bolus of 100% oxygen upon the next inhalation. These devices were originally designed for portable home oxygen therapy. However, they are finding increasing use in acute care settings for patients who are difficult to supply oxygen via standard nasal cannulas and as high-delivery alternatives to oxygen delivery via a face mask.1–3 For example, a reservoir cannula may be used to help prevent reintubation in patients who have chronic lung disease, support oxygenation in patients who are recovering from acute respiratory distress syndrome or have congestive heart failure, and help improve compliance in confused patients who become agitated when a face mask is applied. Understanding the implications of these devices is important to acute care nurses.
In this article, we discuss the implications of oxygen therapy with reservoir cannulas. We include advantages and disadvantages of the cannulas, how these devices operate, their ability to deliver oxygen, possible complications of delivery of high concentrations of oxygen, assessment of pulmonary disease, and a case study.
 |
RESERVOIR CANNULAS
|
|---|
Reservoir cannulas are oxygen-conserving devices. They store 20 mL of oxygen during exhalation and make that oxygen available for the beginning of the next inhalation. They require one half to one fourth the flow rate of standard cannulas at settings of 0.5 to 2 L/min.4–7 These devices are available in 2 configurations: the Oxymizer and the Oxymizer Pendant.
The Oxymizer (Figures 1
and 2) has the reservoir over the mustache area, a location that is more noticeable but is more comfortable for many patients.6 The Oxymizer Pendant has the reservoir hanging on the anterior chest wall, a less noticeable location. However, the pendant is often less comfortable because of the weight on the ear loops.6 Many patients receiving portable oxygen therapy use the Oxymizer at home and the Oxymizer Pendant to go out of the house. Both devices are disposable and are worn like standard cannulas.6
View larger version (102K):
[in this window]
[in a new window]
|
Figure 1 Exhalation: The Oxymizer with a section of the anterior wall cut out to visualize the membrane. The membrane is thrust forward during exhalation, creating a reservoir chamber to collect oxygen.
|
|
View larger version (108K):
[in this window]
[in a new window]
|
Figure 2 Inhalation: The Oxymizer with a section of the anterior wall cut out to visualize the membrane. The membrane is collapsed as oxygen is delivered at the beginning of the next inhalation.
|
|
|
HOW RESERVOIR CANNULAS WORK
|
|---|
Reservoir cannulas depend on patients’ own respiratory effort to cycle and deliver the stored oxygen. The cannula is connected to a source of 100% oxygen in the same way as a standard cannula. As is true of all nasal cannulas, the amount of oxygen actually delivered to a patient’s alveoli depends on the oxygen flow rate and the dilution of that oxygen by entrainment of room air. The dilution by entrainment of room air is determined by factors such as mouth breathing, respiratory rate and pattern, inspiratory flow rate, minute ventilation, and altitude.
With a standard cannula, the continuous flow of oxygen during exhalation and during the last part of inhalation is wasted to the atmosphere.6,7 Reservoir cannulas are designed to store a bolus of highly concentrated oxygen. This feature helps reduce the effect of dilution by entrained room air at normal inspiratory rates. The reservoir contains a thin membrane that is thrust forward at the beginning of exhalation, creating a storage chamber between the membrane and the back wall of the reservoir (Figure 1
). During the remainder of exhalation, oxygen collects in the chamber. When the patient inhales, the stored oxygen is immediately inhaled in addition to the continuous flow of oxygen (Figure 2). Thus, the patient receives a burst of oxygen at the very beginning of inhalation.1,7 This feature concentrates oxygen delivery at the beginning of inhalation, when the delivered oxygen can participate in alveolar capillary gas exchange.
Humidification is not necessary with either standard or reservoir cannulas when low flow rates of 1 to 4 L/min are used. Reservoir cannulas capture exhaled water vapor from patients and return the vapor during inhalation. The vapor is returned at temperatures close to body temperature. Consequently, even without added humidification, reservoir cannulas perform at a higher relative humidity than do standard cannulas. Some clinicians are using added humidification with reservoir cannulas at higher flow rates of 6 to 10 L/min. Contrary to early fears, no condensation and sticking of the membrane inside the reservoir with added humidification have been reported.8
|
OXYGEN DELIVERY
|
|---|
The gas that accumulates in the reservoir of the cannulas is about 80% oxygen at a flow rate of 0.5 L/min and nearly 100% oxygen at a rate of 1 L/min.8 As previously noted, the amount of oxygen actually delivered to the alveoli depends on the multiple factors that affect dilution by entrainment of room air.
Tiep et al8 developed a theoretical model for predicting oxygen delivery by reservoir cannulas that is based on an inspiratory to expiratory ratio of 1:2, a respiratory rate of 20 breaths/min, and an assumption that the most efficacious delivery occurs in the first 0.5 seconds and the first 200 mL of inhalation. These predictions for oxygen delivery have been validated through laboratory experiments.6,8 Studies2,4–7 comparing the efficacy of reservoir cannulas with that of standard cannulas consistently indicate that reservoir cannula flow rates of 0.5, 1, and 2 L/min yield a fraction of inspired oxygen (FIO2) equivalent to that delivered by flow rates of 2, 3, and 4 L/min, respectively, by standard nasal cannulas (Table 1, Figure 3).
View larger version (9K):
[in this window]
[in a new window]
|
Figure 3 Model of oxygen delivery via a reservoir cannula (open squares) versus continuous flow via a standard nasal cannula (filled squares)7
|
|
Currently, not enough scientific data are available to accurately predict the FIO2 delivered by reservoir cannulas at high flow rates. Only a single study3 has been done on the use of reservoir cannulas at high flow rates in acute care. Sheehan and O’Donohue3 found that in 9 of 10 patients, reservoir cannula flow rates of 6 to 8 L/min provided arterial oxygen saturation (SaO2) levels equivalent to the levels provided by an FIO2 of 0.50 to 0.65 delivered via a face mask.
|
BENEFITS OF RESERVOIR CANNULAS
|
|---|
The major benefit of reservoir cannulas is their ability to improve the efficiency of oxygen delivery. Patients require one half to one fourth the flow rate of a standard cannula to achieve an equivalent SaO2.8 This increased efficacy enables patients receiving oxygen at home to carry smaller and more portable oxygen containers and to enjoy an extended time away from home, a therapeutic benefit. In addition, fewer deliveries of oxygen containers are needed, a characteristic that reduces the cost of providing oxygen at home.8
In acutely ill patients who require an FIO2 of 0.50 or more, reservoir cannulas have 2 major advantages. First, the cannulas facilitate treatment by allowing patients to eat, communicate more effectively, ambulate more easily, and use an incentive spirometer without removing the oxygen supply. Second, the enhancement in comfort provided by the cannulas and their acceptability increase patients’ satisfaction. These factors are important in increasing compliance and decreasing agitation and anxiety. In the home setting, patients sometimes regard a reservoir cannula as more obtrusive than a standard cannula. In contrast, in the acute care setting where patients are using reservoir cannulas as an alternative to face masks, the cannulas are more comfortable and more cosmetically acceptable.3,8
|
ASSESSING DEGREE OF PULMONARY DISEASE IN RELATION TO OXYGEN REQUIREMENT
|
|---|
When reservoir cannulas are used, patients receive more oxygen than they would receive at the same flow rate from a standard cannula. As a result, patients attain a higher SaO2 with reservoir cannulas than with standard cannulas. However, this increase in SaO2 does not necessarily mean an improvement in pulmonary status. In fact, the complications attributed to high FIO2 values can contribute to a deterioration in status.
Despite the presence of higher than expected SaO2 values, nurses must frequently assess the pulmonary status of patients who are receiving oxygen via reservoir cannulas in the acute care setting. The assessment should include checking for dyspnea, tachypnea, dysphasic respiration, anxiety, restlessness, diaphoresis, tachycardia, and the use of accessory muscles and auscultation of lung fields. Arterial blood gas analysis should be used to determine the adequacy of ventilation and acid-base balance and, if necessary, to measure the degree of intrapulmonary shunt.
Assessing intrapulmonary shunt requires knowledge of the physiology of gas exchange. Shunt refers to a condition in which pulmonary capillary perfusion is normal, but alveolar ventilation and/or diffusion of gases across the alveolocapillary membrane is lacking. In pulmonary shunt, blood flows from the right side of the heart to the left side without being oxygenated. Normally, less than 10% of the cardiac output is shunted. This normal shunt is due to the blood that flows through the bronchial and thebesian veins. Pathological shunt can be caused by any condition that inhibits the diffusion of oxygen across the alveolocapillary membrane, such as adult respiratory distress syndrome, atelectasis, pneumonia, pulmonary edema, and tumors.
Three methods can be used at the bedside to estimate the degree of shunt: alveolar-arterial gradient (PAO2 - PAO2; A-a gradient), arterial/alveolar ratio (a/A), and PAO2/FIO2 ratio9 (Table 2). Measurement of these parameters requires an arterial blood gas analysis and the FIO2 value. Knowledge of how to use the alveolar gas (PAO2) equation is also necessary for the first 2 parameters (Table 3).
Assessment of intrapulmonary shunt takes into consideration the partial pressure of oxygen available to the alveoli (PAO2) and the actual partial pressure of oxygen in the arterial blood (PAO2). This measurement reflects the effectiveness of oxygen diffusion across the alveolocapillary membrane and therefore gives an estimation of the degree of pulmonary disease. The arterial hemoglobin saturation of oxygen alone, as measured by pulse oximetry (SpO2) or SaO2 from the arterial blood gas analysis, does not reveal the degree of intrapulmonary disease. The amount of oxygen required to attain a specific level of oxygenation must be determined.
|
ADVERSE EFFECTS OF INCREASING FIO2
|
|---|
Oxygen should be treated as a drug that has potential adverse effects. When reservoir cannulas are used, patients are exposed to higher FIO2 values than they are when standard cannulas are used. Unwanted consequences may include worsening atelectasis from hypoventilation, absorption atelectasis, damage to the lung parenchyma from the toxic effects of oxygen free radicals, and suppression of the hypoxic respiratory drive in patients with chronic carbon dioxide retention.
Absorption atelectasis can be the result of several factors. The atmospheric air is composed of a mixture of gases: 21% oxygen, 79% nitrogen, and trace amounts of carbon dioxide and water vapor. In the alveoli, nitrogen accounts for approximately 74.9% of the total gas pressure; about 13.6% is due to oxygen, 5.3% to carbon dioxide, and 6.2% to water vapor. Nitrogen is not absorbed into the capillaries and helps splint the alveoli open while oxygen is being absorbed. When 100% oxygen is administered, nitrogen is displaced, leaving the alveoli to collapse as the oxygen is being absorbed.
Cytotoxic effects caused by oxygen-free radicals are a concern with exposure to high concentrations of oxygen. The normal end product of oxygen metabolism is water. In that process, a few molecules are partially reduced, creating hydrogen peroxide and other destructive irritants. However, the body compensates and protects itself by producing antioxidants, which neutralize these free radicals and break them down.
When the concentration of oxygen becomes too great, the concentration of the free radicals also becomes high enough to overwhelm the body’s defenses and cause tissue damage. Alveolar tissue destruction leads to edema, causing shunt. Shunt causes greater hypoxemia, which requires more oxygen. This vicious cycle can be countered by maintaining
Elevated PaCO2 is normally the primary stimulus for respiration. Patients with chronically elevated levels adapt to the elevation, and PaCO2 becomes a very weak stimulus for respiration. In these patients, PAO2 becomes a more important stimulus for respiration. However, PAO2 has essentially no effect on respiration until it decreases to less than 100 mm Hg. At a PAO2 of 60 mm Hg, respiratory effort doubles. Supplemental oxygen in patients with chronically elevated PaCO2 sometimes causes suppression of respiratory effort. This fact in no way means that oxygen should be withheld from patients who need it. It simply means this danger should be recognized and that patients should be monitored and assisted ventilation used when appropriate.
Increasing the FIO2 is often necessary to maintain oxygenation and prevent tissue hypoxia. Many patients with pulmonary disease respond well to increased oxygen delivery, even high concentrations for a short time. Patients with intrapulmonary shunting have less significant improvement with increased FIO2. These patients require bronchial hygiene, bronchodilators, diuretics, positive-pressure ventilation, and sometimes anti-inflammatory agents to treat the underlying illness. When increasing a patient’s FIO2, clinicians should be aware of potential complications and should monitor the patient more frequently and use therapies to prevent and correct atelectasis.
The case study (shaded box) illustrates the vigilance required for patients using reservoir cannulas at high flow rates.
|
CONCLUSION
|
|---|
Some anecdotal evidence3 indicates that the FIO2 delivered by reservoir cannulas at flow rates greater than 2 L/min may be higher than predicted by calculations. Currently, there is no way to prove or disprove this possibility. We recommend that reservoir cannulas be compared with face masks and continuous flow via standard cannulas to determine FIO2 equivalencies at higher flow rates.
Reservoir cannulas can be a valuable adjunct in the acute care setting. They should be used judiciously as an alternative to a face mask in patients who have refractory hypoxemia and require 50% or more oxygen. However, staff must be alert to the presence and severity of intrapulmonary disease that would require an FIO2 greater than 0.50. Any time a patient using a reservoir cannula requires a flow rate greater than 4 L/min, severe pulmonary disease must be suspected, and appropriate evaluation, monitoring, and therapies must be instituted.
|
References
|
|---|
- Gonzales SC, Huntington D, Romo R, Light R. Efficacy of the Oxymizer Pendant in reducing oxygen requirements of hypoxemic patients. Respir Care. 1986;31:681–688.
- Soffer M, Tashkin DP, Shapiro BJ, Littner M, Harvey E, Farr S. Conservation of oxygen supply using a reservoir nasal cannula in hypoxemic patients at rest and during exercise. Chest. 1985;88:663–668.[Abstract/Free Full Text]
- Sheehan JC, O’Donohue WJ. Use of a reservoir nasal cannula in hospitalized patients with refractory hypoxemia [abstract]. Chest. 1996;110:1S.[Medline]
- Hagarty EM, Skorodin MS, Stiers WM, Mamdani MB, Jessen JA, Belingon EC. Performance of a reservoir nasal cannula (Oxymizer) during sleep in hypoxemic patients with COPD. Chest. 1993;103: 1129–1134.[Abstract/Free Full Text]
- Carter R, Williams JS, Berry J, Peavler M, Griner D, Tiep B. Evaluation of the pendant oxygen-conserving nasal cannula during exercise. Chest. 1986;89:806–810.[Abstract/Free Full Text]
- Tiep BL, Belman MJ, Mittman C, Phillips R, Otsap B. A new pendant storage oxygen-conserving nasal cannula. Chest. 1985;87:381–383.[Abstract/Free Full Text]
- Tiep BL, Nicotra B, Carter R, Belman MJ, Mittman C Evaluation of a low-flow oxygen-conserving nasal cannula. Am Rev Respir Dis. 1984;130:500–502.[Medline]
- Tiep BL. Portable Oxygen Therapy: Including Oxygen-Conserving Methodologies. Armonk, NY: Futura Publishing Co Inc; 1991.
- Ahrens T. Respiratory monitoring. In: Clochesy JM, Breu C, Cardin S, Whittaker AA, Rudy EB, eds. Critical Care Nursing. 2nd ed. Philadelphia, Pa: WB Saunders Co; 1996:253–256.
This article has been cited by other articles:
|
|
|
|
 
B.R. Celli, W. MacNee, A. Agusti, A. Anzueto, B. Berg, A.S. Buist, P.M.A. Calverley, N. Chavannes, T. Dillard, B. Fahy, et al.
Standards for the diagnosis and treatment of patients with COPD: a summary of the ATS/ERS position paper
Eur. Respir. J.,
June 1, 2004;
23(6):
932 - 946.
[Full Text]
[PDF]
|
|
|
Top
RESERVOIR CANNULAS
HOW RESERVOIR CANNULAS WORK
